Details for New Drug Application (NDA): 202912
✉ Email this page to a colleague
The generic ingredient in ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE is abacavir sulfate; lamivudine; zidovudine. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.
Summary for 202912
Tradename: | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE |
Applicant: | Lupin Ltd |
Ingredient: | abacavir sulfate; lamivudine; zidovudine |
Patents: | 0 |
Pharmacology for NDA: 202912
Mechanism of Action | Cytochrome P450 1A1 Inhibitors Nucleoside Reverse Transcriptase Inhibitors |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 300MG BASE;150MG;300MG | ||||
Approval Date: | Dec 5, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription